POZ Focus - Different Treatments for Different Populations

Switching to a long-acting injectable was right on time for these three people living with HIV.

By Heather Boerner

Under 30? Here’s what to consider if you’re thinking about switching HIV treatments.

By Heather Boerner

Here are considerations for long-term survivors thinking about switching HIV treatments.

By Heather Boerner

#NYHAAD is Saturday, April 10, and youth HIV advocates want your help to repeal HIV discrimination. Here’s their plan.

By Trent Straube

People 55 and older make up 37% of the U.S. HIV population. Most are undetectable. What’s more, PrEP use increased among this age group.

By Trent Straube

Articles